The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Agios
Stock and Other Ownership Interests - Agios
Consulting or Advisory Role - Advance Medical
Ivosidenib (IVO; AG-120) in mutant IDH1 relapsed/refractory acute myeloid leukemia (R/R AML): Results of a phase 1 study.
 
Daniel Aaron Pollyea
Consulting or Advisory Role - Abbvie; Agios; argenx; Celgene; Celyad; Curis; Pfizer; SERVIER
Research Funding - Agios (Inst); Pfizer (Inst)
 
Courtney Denton Dinardo
Honoraria - Agios; Daiichi Sankyo; Novartis
Research Funding - Abbvie; AGIOS; Celgene; Daiichi Sankyo; Novartis
 
Stéphane de Botton
Consulting or Advisory Role - Agios; Celgene; Novartis; Pfizer; Pierre Fabre; SERVIER
Research Funding - Agios
 
Eytan Stein
Consulting or Advisory Role - Agios; Bayer; Celgene; Novartis; Pfizer
 
Gail J. Roboz
Consulting or Advisory Role - Abbvie; Amgen; Amphivena; argenx; Array BioPharma; Astex Pharmaceuticals; Bayer; Celgene; Cellectis; Celltrion; Clovis Oncology; CTI; Eisai; Genentech/Roche; Genoptix; Immune Pharmaceuticals; Janssen; Jazz Pharmaceuticals; MedImmune; Novartis; Orsenix; Pfizer; Sandoz; Sunesis Pharmaceuticals
Research Funding - Abbvie (Inst); Agios (Inst); Astex Pharmaceuticals (Inst); Celgene (Inst); Cellectis (Inst); CTI (Inst); Karyopharm Therapeutics (Inst); MedImmune (Inst); MEI Pharma (Inst); Moffitt (Inst); Novartis (Inst); Onconova Therapeutics (Inst); Pfizer (Inst); Sunesis Pharmaceuticals (Inst); Tensha Therapeutics (Inst)
Travel, Accommodations, Expenses - Abbvie; Amgen; Amphivena; Array BioPharma; Astex Pharmaceuticals; Bayer; Celgene; Celltrion; Clovis Oncology; Eisai; Janssen; Jazz Pharmaceuticals; Novartis; Pfizer; Roche/Genentech; Sandoz; Sunesis Pharmaceuticals
 
Alice S. Mims
Consulting or Advisory Role - Agios
Speakers' Bureau - Novartis
 
Ronan T. Swords
No Relationships to Disclose
 
Jessica K Altman
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Immune Pharmaceuticals; Janssen; Novartis; Syros Pharmaceuticals
Research Funding - ARIAD (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Celator (Inst); Celgene (Inst); Cyclacel (Inst); Epizyme (Inst); Fujifilm (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Pfizer (Inst)
 
Robert Collins
Employment - University of Texas Southwestern Medical Center - Simmons Cancer Center
Honoraria - OptumHealth
Research Funding - Agios; Arog; Bristol-Myers Squibb; Celgene
 
Gabriel N. Mannis
Consulting or Advisory Role - Amgen; Curis
Research Funding - Agios (Inst); Juno Therapeutics (Inst)
 
Geoffrey L. Uy
Consulting or Advisory Role - Curis; Glycomimetics; Jazz Pharmaceuticals; Novartis; Novo Nordisk; Pfizer
Travel, Accommodations, Expenses - Novartis
 
William Bruce Donnellan
No Relationships to Disclose
 
Arnaud Pigneux
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Gilead Sciences; Incyte; Janssen; Jazz Pharmaceuticals; Merck Sharp & Dohme; Novartis; Pfizer; Sanofi
Research Funding - Amgen; Celgene; Gilead Sciences; Incyte; Janssen; Novartis
Travel, Accommodations, Expenses - Abbvie; Jazz Pharmaceuticals; Sanofi
 
Amir Tahmasb Fathi
Honoraria - Agios; Baxalta; Merck; Seagen; Tolero Pharmaceuticals
Research Funding - Celgene (Inst); Exelixis (Inst); Seagen (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Agios
 
Hua Liu
Employment - Agios
Stock and Other Ownership Interests - Agios
 
Bin Wu
Employment - Agios
Stock and Other Ownership Interests - Agios
Patents, Royalties, Other Intellectual Property - Agios (Inst)
 
Eyal C. Attar
No Relationships to Disclose
 
Martin S. Tallman
Consulting or Advisory Role - Agios; Daiichi Sankyo; Orsenix
Research Funding - ADC Therapeutics; Arog; BioLineRx; Cellerant; Daiichi Sankyo; Orsenix
Travel, Accommodations, Expenses - American Society of Hemotology; Chinese Medical Association; Educational Forum in Israel; Emirates Society of Haematology; European School of Haematology; France Foundation; George Washington University; Hematology Oncology of Indiana; Lynn Cancer Institute; Mayo Clinic; Novartis; Rambam Health Care; Rush University; St Vincent's Hospital; Sylvester Cancer Center; University of Pittsburgh Medical Center
 
Richard M. Stone
Consulting or Advisory Role - Abbvie; Agios; Amgen; Bristol-Myers Squibb; Celator; Celgene; Fujifilm; Juno Therapeutics; Karyopharm Therapeutics; Merck; Novartis; Ono Pharmaceutical; Roche/Genentech; Theradex
Research Funding - Agios (Inst); Celator (Inst); Karyopharm Therapeutics (Inst); Novartis (Inst)
 
Hagop M. Kantarjian
Honoraria - Abbvie; Amgen; ARIAD; Bristol-Myers Squibb; Immunogen; Orsenix; Pfizer
Research Funding - Amgen (Inst); ARIAD (Inst); Astex Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer (Inst)